TABLE 7.
PDVs | Contacts | Clinical significance of contact variants | |||||||
---|---|---|---|---|---|---|---|---|---|
Domain | State | WT | Variants | WT | Variants | VUS | P/LP | NP | CIP |
PD | Inactivated a | 27 | 38 | 37 | 49 | 29 | 7 | 11 | 2 |
Open b | 3 | 5 | 2 | 2 | 1 | ||||
Closed b | 5 | 9 | 2 | 1 | 5 | 1 | |||
VSD-I | Activated a | 5 | 13 | 11 | 15 | 8 | 1 | 2 | 4 |
Resting c | 1 | 3 | 3 | 6 | 2 | 2 | 2 | ||
VSD-II | Activated a | 4 | 5 | 8 | 10 | 8 | 2 | ||
Resting c | 6 | 10 | 6 | 2 | 2 | ||||
VSD-III | Activated a | 3 | 7 | 4 | 6 | 4 | 1 | 1 | |
Resting c | 1 | 1 | 1 | ||||||
VSD-IV d | Activated a | 4 | 5 | 4 | 4 | 3 | 1 | ||
Resting c | 2 | 3 | 1 | 2 | |||||
Total | 10 | 11 | |||||||
54 | 82 | 84 | 118 | 65 | 14 | 25 | 14 | ||
Set e | w54 | PDV | c84 | cv118 |
Cryo-EM structure.
WT residues that have contacts variants in the inactivated PD (cryo-EM structure) are not counted.
WT residues that have contacts variants in the activated VSD (cryo-EM structure) are not counted.
Location is not shown for WT residues that do not form contacts with disease-associated residues.
Names of the sets are shown in bold.